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ABSTRACT Previous studies have dem-
onstrated a defect associated with the
calcium release mechanism of sarco-
plasmic reticulum (SR) from individuals
susceptible to malignant hyperthermia
(MH). To examine whether SR calcium
release channels were indeed altered
in MH, SR vesicles were purified from
normal and MH susceptible (MHS) por-
cine muscle. The Ca2+ dependence of
calcium efflux rates from 45Ca2+-filled
SR vesicles was then compared with
the Ca2+ dependence of single-chan-
nel recordings of SR vesicles incorpo-
rated into planar lipid bilayers. The rate
constants of 45Ca2' efflux from MHS SR
were two to threefold larger than from
normal SR over a wide range of myo-
plasmic Ca2+. Normal and MHS single
channels were progressively activated
in a similar fashion by cis Ca2+ from
pCa 7 to 4. However, below pCa 4,
normal channels were inactivated by
cis Ca2 , whereas MHS channels
remained open for significantly longer
times. The altered Ca2+ dependence of
channel inactivation in MHS SR was
also evident when Ca2+ was increased
on the trans side while cis Ca2+ was
held constant. We propose that a
defect in a low-affinity Ca2' binding site
is responsible for the altered gating of
MHS SR channels. Such a defect could
logically result from a mutation in the
gene encoding the calcium release
channel, providing a testable hypothe-
sis for the molecular basis of this inher-
ited disorder.
INTRODUCTION
Malignant hyperthermia (MH) is an inherited pharma-
cogenetic disorder characterized by an accelerated skele-
tal muscle metabolism, muscle rigidity, and rapidly rising
body temperature (1, 2). MH is triggered in as many as
one in 15,000 anesthetic procedures, and can be fatal if
not treated promptly (3-5). Numerous reports indicate
that regulation of myoplasmic Ca2" is abnormal in MH
susceptible (MHS) individuals, primarily due to an
abnormality in the sarcoplasmic reticulum (SR) Ca2"
release mechanism (6-11). The defect appears closely
associated with the ryanodine receptor, the protein that
forms the SR Ca release channel (12-16), because bind-
ing of [3H]ryanodine to MHS SR exhibits an altered
Ca2' dependence and a higher affinity for ryanodine than
normal SR (17).
In this paper we show that ryanodine receptor channels
from the SR of a homozygous recessive pig model of MH
(18) remain open significantly longer than do channels
from homozygous normal animals. This is due to the
failure of MHS channels to inactivate in physiological
Ca2+ gradients, and appears to result from an altered
low-affinity Ca2' binding site in the channel pore. This
alteration may have resulted from a mutation in the gene
encoding for the ryanodine receptor.
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Heavy SR vesicles from the longissimus dorsi muscle of MHS and
normal pigs were prepared in the presence of a cocktail of protease
inhibitors (PMSF, benzamidine, leupeptin, pepstatin, and aprotinin)
(17) using discontinuous sucrose gradient centrifugation (19), and did
not differ in Ca2+-ATPase activity, phospholipid and cholesterol con-
tent, or the Coomassie blue staining pattern on SDS polyacrylamide gels
(9, 17). Vesicles were stored at - 800C until used. All pigs were obtained
from a herd maintained by Dr. William Rempel, of the Department of
Animal Science at the University of Minnesota, for genetic studies of
MH inheritance. The pigs were tested for MH susceptibility by a
halothane challenge test (exposure to 3% halothane in oxygen by mask),
with the MHS Pietrain strain (homozygous for the gene responsible for
MH) responding to the test with limb muscle rigidity in <4 min
exposure; the normal Yorkshire strain of pigs (homozygous for the
normal allele) did not react to the halothane test.
To determine the rate constant of calcium release, SR vesicles (1.5
mg/ml) were first passively loaded with 43Ca2+ for 2 h at 220C in 0.1 M
KCI, 20 mM Pipes (pH 7.0), 5 mM CaC12 (containing 0.5 mCi/ml
45Ca2,). Under these conditions both MHS and normal SR loaded in the
range 50-75 nmol Ca/mg SR; there was no difference in the Ca loading
of these two types of SR (9). Calcium release was initiated by rapid
mixing (Update System 1000 Chemical/Freeze Quench Apparatus,
Update Instruments Inc., Madison, WI) of the 45Ca2+-loaded SR
vesicles with solutions containing 0.1 M KCI, 20mM Pipes (pH 7.0) and
various EGTA plus nitriloacetic acid-containing media to obtain the
indicated final Ca2, concentrations (17). Calcium release was stopped
at various times after the initial mixing (50-600 ms depending on the
rate of release) by further rapid mixing with 0.1 M KCI, 20 mM Pipes,
10 gM ruthenium red, 10 mM MgCl2, 10 mM EGTA (final concentra-
tions), and the SR calcium content was determined after filtration of
samples on 0.45-am filters (Millipore/Continental Water Systems,
Bedford, MA) (20). Rate constants of calcium release were determined
from semilogarithmic plots of SR calcium content vs. time as described
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by Meissner et al. (20). The SR calcium content was in all cases
corrected for the nonreleasable calcium component (18, 20). The driv-
ing force for Ca2" release (Ec,) was calculated from an Eyring rate
model (21) restricted to conduction in single-file with three free energy
peaks and two free energy wells. Parameters that fit current-voltage
curves of release channels under the same conditions of efflux experi-
ments are:
Ion El E2 E3 E4 Es
K 9.0 -1.0 4.0 -1.0 9.0
Ca 3.5 -10.0 2.0 -10.0 3.5
Where E,, E3, and Es are free energy peaks in RT units; E2 and Es are
free energy wells in RT units. Peaks and wells are located symmetrically
within the electric field.
Planar lipid bilayers were formed by the Mueller-Rudin method in
Delrin partitions with apertures of 300 ,m. The decane-lipid mixture
was composed of bovine brain phosphatidylethanolamine and phosphati-
dylserine each at 10 mg/ml (Avanti Polar Lipids, Inc., Birmingham,
AL). The cis side was connected to the head-stage input of a model EPC
7 amplifier (List-Electronic, Eberstadt, FRG). The trans side was held
at virtual ground. Data was stored on FM tape, played back, and filtered
at a corner frequency of 2 KHz using an eight-pole Bessel filter, and
digitized for computer analysis at 71 KHz using a 12-bit A/D converter.
Recording solutions were 250 mM CsCl in the cis chamber (connected
to the headstage amplifier), and 50 mM CsCl in the trans chamber
(connected to ground). Buffer in both compartments was 20 mM
MOPS, pH 7.2. In approximately 30% of vesicle fusions, release
channels could be recorded in the absence of Cl- channels and these
cases were used for analysis. The total recording time was -1,200
minutes from seven preparations each of normal and MHS SR.
RESULTS AND DISCUSSION
To examine whether ryanodine receptor channels were
altered in MH, we purified SR vesicles from normal and
MHS muscle and compared the Ca2" dependence of
45Ca2" efflux rates with that of single-channel recordings
in planar lipid bilayers. Fig. 1 shows that Ca2"-induced
Ca2" release is more prominent in MHS SR because
efflux rate constants are two- to threefold larger than
from normal SR over a wide range of myoplasmic Ca2".
The Ca2" concentration required to activate the Ca2"
release rate by 50% was 0.30 ± 0.18 AM and 0.31 ± 0.04
,uM, for three preparations each of MHS and normal SR,
respectively; in both cases, maximal release rates were at
-6 ,uM Ca2". In these experiments the driving force for
Ca2" efflux decreased as the Ca2" gradient decreased. A
theoretical calculation of the decrease in driving force for
Ca2" (ECa) as a function of extravesicular Ca2" and
constant 5 mM intravesicular Ca2" is shown in the inset of
Fig. 1. Eca decreases continuously with myoplasmic Ca2"
and is essentially zero at concentrations > 100 ,uM. Thus,
absolute efflux rates at high Ca2" may be largely underes-
timated by this experimental approach.
To further define the basis for the increased Ca release
rate from MHS SR, and its regulation by Ca2", we
examined recordings of single release channels incorpo-
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FIGURE 1 Ca2"-dependence of Ca2" release from MHS (solid circles)
and normal (open circles) SR vesicles. Points represent means ± SE for
three preparations each ofMHS and normal SR. Inset shows the driving
force for Ca2" release (Ec.) as a function of extravesicular Ca2" and
constant 5 mM intravesicular Ca2". Ec. is the difference between the
Nernst potential for the Ca2" gradient and the reversal potential for the
release channel.
rated into planar lipid bilayers. The polarity of the
inserted channels was found to be the same as in previous
studies (22), i.e., the myoplasmic side facing into the cis
solution and the intravesicular side facing into the trans
solution. A gradient of Cs' instead of Ca2" was used as
current carrier (250 mM CsCl on the cis side and 50 mM
CsCl on the trans side) (a) to avoid the use of large Ca2"
gradients which decrease the activity of release channels
(15); (b) to eliminate the interference from SR K+
channels, because these are actually blocked by Cs' (23);
and (c) because Cs' has a higher conductance than Ca2+
or Na+ through release channels (gc,/gca = 2) (14) and
thus is useful in improving the signal to noise ratio. SR Cl
channels were separated from release channels on the
basis of reversal potential (Ec- = + 37 mV; ECS+ =-37
mV).
The effect of four regulators of SR Ca2' release
channels, namely ATP and ryanodine (activators), and
Mg2+ and ruthenium red (inhibitors) (20, 22) are shown
in Fig. 2. In the control periods before additions (10uM
cis free Ca2+, + 20 mV holding potential), MHS channels
had a 12% higher conductance than normal channels (438
pS ± 34, n = 6 for MHS; 383 pS ± 24, n = 7 for normal;
P < 0.01). ATP increased open probability in both cases
by approximately threefold above control (3.1-fold ± 1.2,
n = 4 for MHS; 2.9-fold ± 1.2, n = 4 for normal). Ry-
anodine modified gating of normal and MHS channels in
the characteristic way, by decreasing conductance and
increasing mean open time (14). Likewise, ruthenium red
and millimolar Mg2` blocked all activity seen in controls.
These results confirmed that Ca2+ release channels in
normal and MHS SR are functional, and display pharma-
cological characteristics already recognized in SR of
rabbit skeletal muscle (20, 22).
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FIGURE 2 Ca2" release channels from normal and MHS SR. Holding potential in all records was + 20 mV. Ca2, was present at contaminant levels
(6-11 MAM). Lines to the left of each record indicate baseline. All additions, including SR protein, were to the cis chamber. Records labeled control,
ATP, and ryanodine are from the same experiment, whereas records labeled ruthenium red and Mg2+ are from separate experiments. (A) Normal
channel; (B) MHS channel. Desired free Ca2+ was obtained using Ca2+-EGTA buffers and confirmed with Ca2' electrode and Ca2' dye methods.
The Ca2" dependence of normal and MHS channels as
a function of cis Ca2" is shown in Fig. 3. Open probabili-
ties, PO (Fig. 3, top), were computed in the range of cis
pCa 7 to pCa 2, while keeping trans Ca2" constant at 10
,uM. At cis 10 AM Ca2", P. of normal and MHS channels
did not differ significantly (0.211 ± 0.130;
0.207 ± 0.116, respectively). Normal and MHS channels
were progressively activated by cis Ca2" from pCa 7 to 4,
which was similar to the concentration range required to
activate Ca2"-induced 45Ca2" release from SR vesicles
(Fig. 1). However, below pCa 4, normal channels were
inactivated by cis Ca2", whereas MHS channels
remained open for significantly longer times. For
instance, normal channels are essentially closed at 1 mM
cis Ca2", whereas in MHS channels, the same activity
seen at 10 ,M is also observed in 1 mM cis Ca2". The
Ca2" level at which channel activity was 50% of that
recorded at 10 ,uM cis Ca2" differed by an order of
magnitude, -200 MM in normal and 2.5 mM Ca2" in
MHS channels.
The open time histograms at three cis Ca2" concentra-
tions is shown in the bottom of Fig. 3. The lifetime of
normal and MHS channels at 10 ,M cis Ca2" was best
described by a single exponential distribution with similar
mean open times of 1.1 ms (1,743 events) and 1.0 ms
(1,255 events), respectively. At 1 mM Ca2", histograms
of normal channels remained monoexponential (mean
lifetime of 0.4 ms, 434 events), whereas those of MHS
channels showed in addition to the brief events with a
lifetime of 1.5 ms, a tail distribution of longer events with
a mean lifetime of 13.9 ms (294 events). Evidently, MHS
channels not only failed to inactivate in high cis Ca2", but
also remained open for longer times.
The altered Ca2" dependence of channel inactivation in
MHS SR was also evident when Ca2" was increased on
the trans side while cis Ca2+ was held constant at
physiological levels. In Fig. 4, channels were first incorpo-
rated in symmetrical 10 MM free Ca2' and afterwards
trans free Ca2, was raised to the indicated value. Control
activity in symmetrical 10 MM Ca2, was deliberately
chosen to be high (channels with P0 < 0.2 were rejected)
so that the decrease in P0 in normal channels in high trans
Ca2, could be adequately measured. Previous studies
have demonstrated that millimolar trans Ca2+ inactivates
K+ movement through rabbit SR Ca channels (15). With
Cs' as the permeant ion, high trans Ca2' resulted in the
permanent closure of three of five normal pig SR chan-
nels; one of these cases is shown in Fig. 4. That not all
normal channels inactivated completely in high trans
Ca2, may explain why channels can be recorded using
large trans Ca2, gradients (22). It is thus possible that
two types of ryanodine receptor channels may be present
in the SR, a predominant trans Ca2+-dependent inactivat-
ing type, and a less frequent trans Ca2+-dependent non-
inactivating type. The P0 in cis 10 MM/trans 940 AM
Ca2, was 0.23 ± 0.29 for five normal channels, and
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FIGURE 3 Ca2" dependence of normal and MHS release channels.
(Top) PO is plotted as a function of the free cis [Ca2"]. Free trans [Ca2"]
was held constant at 10 MM. The P0 at each [Ca2"] was determined from
10 to 12 recordings (1,000 ms each) taken at 6-s intervals. To compare
normal and MHS channels, the data was normalized to the value at cis
10 ,M Ca2, (which did not differ) by dividing by the PO at cis 10 4M
Ca2" and multiplying by 20. Each point represents the mean ± SD of
four to seven experiments. Data was collected from two different
preparations of MHS and normal SR. (Bottom) Histograms of cumula-
tive events (percent of open events of duration time t or longer plotted as
a function of t) for representative normal and MH channels.
0.71 ± 0.17 for 3 MHS channels (P < 0.03), where each
channel was studied in a different SR preparation. The P.
values were computed from a pool of 32 1-s segments in
the case of normal, or from 31 1-s segments in the case of
MHS SR. This characteristic failure ofMHS channels to
inactivate in high trans Ca2" appeared as the most likely
explanation for the higher rate of 45Ca2" efflux observed
in MHS SR (Fig. 1). On the other hand, the unit currents
decreased by -55% in MHS and 12% in normal at the
highest Ca2" concentration tested (10.5 ± 0.8 pA and
16.2 ± 0.18 pA, respectively, at + 20 mV). Clearly, trans
Ca2+ decreased the open channel current to a much
greater extent in the MHS than in the normal channel
suggesting that Ca2+ ions, as they pass through the pore,
bind more tightly to the MHS than to the normal channel
( 14). However, because the turnover rates of ion transport
are so high even for the MHS channel in high Ca2+
(-6 x 107 s-'), it is unlikely that the rate of ion passage
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FIGURE 4 Effect of trans Ca2" on normal and MHS release channels.
Normal and MHS channels are shown at the indicated free Ca2" at + 20
mV, after incorporation in symmetrical 10 ,uM Ca2` (top records). PO
was measured from 10-20 segments, each of 1,000 ms duration. In the
records shown, average P. at 940 AM trans Ca2` was <0.001 for normal
and 0.75 for MHS. Lines indicate baseline current.
through open channels is in fact the rate determining step
of 45Ca2" efflux in Fig. 1.
Previous studies suggested that the higher Ca2" perme-
ability of MHS SR vesicles could not be readily explained
by an increase in the density of release channels. Thus,
the amount of the 400-450 kD protein in Coomassie blue
stained gels, and the Bma, of the ryanodine receptor in the
presence of 6 ,uM Ca2", was similar for MHS and normal
SR (17). We have performed further ryanodine binding
experiments in the presence of 6 ,IM Ca2" plus 10 mM
ATP, which promotes optimal binding of ryanodine
(12, 17), and find that MHS and normal SR have
a similar receptor density under these conditions
(Bmax = 14.8 ± 1.5 pmol/mg, and 15.9 ± 0.9 pmol/mg).
That the higher Ca2" permeability of MHS SR vesicles is
due to an altered Ca2" dependence of ryanodine receptor
channels appears even more likely. Because ryanodine
binds with a higher affinity to the open state than to the
closed state of the release channel (12, 24), a prolonged
open state of the MHS channel could readily explain the
higher binding affinity of ryanodine to MHS SR (17).
Furthermore, the lower intravesicular Ca2" threshold for
initiation of Ca2" release from MHS SR reported by
others (10, I 1) may also be a result of a diminished ability
of intravesicular (trans) calcium to inactivate MHS
channels. We suggest that a defect in a low-affinity Ca2"
binding site is responsible for the altered gating of MHS
channels, and envision this site as occupying the interior
of the ion conduction pathway because it is accessible
from both sides of the SR membrane. Furthermore, it
must have a low affinity for Ca2" because in symmetrical
10 ,uM Ca2", that is in the absence of a Ca2" gradient,
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there was no significant difference in open probability
between normal and MHS channels (Fig. 2).
Because the site of action of both halothane (25) and
caffeine (26) appears to be the ryanodine receptor chan-
nel, the defect we have observed in the Ca2" release-
ryanodine receptor channel could also underlie the
increased sensitivity of MHS muscle to contractures
induced by halothane and/or caffeine (1, 2, 6, 7). Such a
defect could logically result from a mutation in the gene
encoding the ryanodine receptor, providing an explana-
tion for the molecular basis of this inherited disease. This
makes the MHS SR a valuable model in the study of
intracellular Ca2" regulation and the molecular mecha-
nism of excitation-contraction coupling.
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